With the help of BioNTech and CEPI's $8.4 million, Imperial College London will work on a self-amplifying RNA vaccine platform.

Here is some other vaccine news of note for the week.

Based in Oxford and slated to open in 2022, the center will focus on creating rapid, cost-effective ways of developing and manufacturing vaccines.

Vaccine trust has fallen in the Philippines since Sanofi's Dengvaxia controversy, and now experts are warning about the threat of measles outbreaks.

A vaccine expert said the anti-vaccine movement is causing its first deaths and subjecting women to cervical cancer for "phony" reasons.

The number of flu shots that passed Chinese regulators so far this season has fallen about 19%, leaving the country short on needed supplies.

After a study showed meningitis B vaccines can protect against gonorrhea, Bexsero maker GSK is weighing whether its vaccine can fight the disease.

Here is some other vaccine news of note for the week.